Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Am J Hematol. 2014 Mar 3;89(6):591–597. doi: 10.1002/ajh.23695

Figure 3.

Figure 3

(A) Overall survival, (B) progression-free survival, (C) cumulative incidence of NRM and (D) relapse by WBC risk group. 0: reference group, 1: low WBC during the first 3 months of HCT; 2: high WBC during the first 3 months of HCT.